110 related articles for article (PubMed ID: 30652071)
1. Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer.
Qu H; Su Y; Yu L; Zhao H; Xin C
FEBS Open Bio; 2019 Jan; 9(1):26-34. PubMed ID: 30652071
[TBL] [Abstract][Full Text] [Related]
2. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
Hou Y; Hou L; Liang Y; Zhang Q; Hong X; Wang Y; Huang X; Zhong T; Pang W; Xu C; Zhu L; Li L; Fang J; Meng X
Neoplasia; 2020 Nov; 22(11):590-603. PubMed ID: 32992138
[TBL] [Abstract][Full Text] [Related]
3. The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.
Lapham A; Adams JE; Paterson A; Lee M; Brimmell M; Packham G
Gene; 2009 Mar; 432(1-2):112-7. PubMed ID: 19124064
[TBL] [Abstract][Full Text] [Related]
4. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
[TBL] [Abstract][Full Text] [Related]
5. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
Wang L; Yu P
Oncol Rep; 2016 Dec; 36(6):3225-3232. PubMed ID: 27779716
[TBL] [Abstract][Full Text] [Related]
6. OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, Proliferation and Epithelial-Mesenchymal Transition: Evidence from Bioinformatics Data Mining and Experimental Verification.
Guo S; Sun Y
Cancer Manag Res; 2022; 14():1371-1384. PubMed ID: 35418782
[TBL] [Abstract][Full Text] [Related]
7. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
8. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
9. AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.
Casado J; Iñigo-Chaves A; Jiménez-Ruiz SM; Ríos-Arrabal S; Carazo-Gallego Á; González-Puga C; Núñez MI; Ruíz-Extremera Á; Salmerón J; León J
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604612
[TBL] [Abstract][Full Text] [Related]
10. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
11. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
Solomon H; Dinowitz N; Pateras IS; Cooks T; Shetzer Y; Molchadsky A; Charni M; Rabani S; Koifman G; Tarcic O; Porat Z; Kogan-Sakin I; Goldfinger N; Oren M; Harris CC; Gorgoulis VG; Rotter V
Oncogene; 2018 Mar; 37(12):1669-1684. PubMed ID: 29343849
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
De Angelis P; Stokke T; Smedshammer L; Lothe RA; Lehne G; Chen Y; Clausen OP
Br J Cancer; 1995 Aug; 72(2):307-11. PubMed ID: 7640210
[TBL] [Abstract][Full Text] [Related]
14. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness.
Li D; Lin C; Li N; Du Y; Yang C; Bai Y; Feng Z; Su C; Wu R; Song S; Yan P; Chen M; Jain A; Huang L; Zhang Y; Li X
EBioMedicine; 2019 Jul; 45():124-138. PubMed ID: 31279780
[TBL] [Abstract][Full Text] [Related]
15. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
Rokavec M; Bouznad N; Hermeking H
Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
[TBL] [Abstract][Full Text] [Related]
16. LKB1 loss at transcriptional level promotes tumor malignancy and poor patient outcomes in colorectal cancer.
He TY; Tsai LH; Huang CC; Chou MC; Lee H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S703-10. PubMed ID: 24879590
[TBL] [Abstract][Full Text] [Related]
17. p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer.
Wen S; Gao J; Zhang L; Zhou H; Fang D; Feng S
Oncotarget; 2016 Nov; 7(46):75981-75995. PubMed ID: 27732955
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
[TBL] [Abstract][Full Text] [Related]
19. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
[TBL] [Abstract][Full Text] [Related]
20. ArhGAP30 promotes p53 acetylation and function in colorectal cancer.
Wang J; Qian J; Hu Y; Kong X; Chen H; Shi Q; Jiang L; Wu C; Zou W; Chen Y; Xu J; Fang JY
Nat Commun; 2014 Aug; 5():4735. PubMed ID: 25156493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
